Daptomycin

Chemical formula: C₇₂H₁₀₁N₁₇O₂₆  Molecular mass: 1,620.693 g/mol  PubChem compound: 16134395

Therapeutic indications

Daptomycin is indicated for:

Complicated skin and soft-tissue infections (cSSTI)

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Adult patients with complicated skin and soft-tissue infections (cSSTI).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Right-sided infective endocarditis (RIE) due to Staphylococcus aureus

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Adult patients with right-sided infective endocarditis (RIE) due to Staphylococcus aureus. It is recommended that the decision to use daptomycin should take into account the antibacterial susceptibility of the organism and should be based on expert advice.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Complicated skin and soft-tissue infections (cSSTI)

Population group: only children (1 year - 12 years old)

Paediatric (1 to 17 years of age) patients with complicated skin and soft-tissue infections (cSSTI).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.